Case Control Study
Copyright ©The Author(s) 2024.
World J Diabetes. Aug 15, 2024; 15(8): 1717-1725
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1717
Table 7 Estimation of risks according to antibodies
Variable
Odds ratio early insulin requirements (n = 132)
OR adj (95%CI)
P value
Anti-GAD652.42 (1.112- 5.303)0.026
Anti-IA21.55 (0.859- 2.818)0.101
Anti-Zn8T7.32 (2.039-26.279)0.002
Anti-GAD65 + Anti-IA23.34 (1.136- 9.814)0.028
Anti-GAD65 + anti-Zn8T4.35 (1.168-16.248)0.028
Anti-IA2 + anti-Zn8T5.34 (1.123-25.431)0.035
Anti-GAD65 + Anti-IA2 + anti-Zn8T5.34 (1.123-25.431)0.035